News Wrap: FDA approves Pfizer's COVID-19 booster for children age 5 to 11

News Wrap: FDA approves Pfizer’s COVID-19 booster for children age 5 to 11

In our news wrap Tuesday, the FDA authorized Pfizer’s low-dose COVID booster for kids 5 to 11 years old, China restricted more Beijing residents to their homes to help control a small outbreak, U.S highway deaths shot up last year…

Read More »